Zoetis reported $5.22B in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aerie Pharmaceuticals AERI:US $ 312.13M 0.45M
Bayer BAYN:GR € 38061M 1413M
Bristol Myers Squibb BMY:US $ 37107M 343M
Charles River Laboratories CRL:US $ 2997.22M 321.06M
Eli Lilly And LLY:US $ 14692M 460.9M
Henry Schein HSIC:US $ 769M 4M
Horizon Pharma HZNP:US $ 2550.99M 1.75M
Idexx Laboratories IDXX:US $ 768M 5.39M
Illumina ILMN:US $ 1241M 454M
IQVIA Holdings Inc IQV:US $ 12.62B 68M
JAZZ PHA JAZZ:US $ 5990M 2.87M
Laboratory Of America LH:US $ 5442.2M 24.3M
Lannett LCI:US $ 610.08M 6.6M
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Perrigo Ordinary Shares PRGO:US $ 4086.1M 575.5M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Quest Diagnostics DGX:US $ 3983M 2M
Teva Pharmaceutical Industries TEVA:US $ 20363M 477M
Zoetis ZTS:US $ 5221M 7M